论文部分内容阅读
深圳市海王英特龙生物技术有限公司隶属于深圳海王集团股份有限公司,成立于1999年1月,是“海王生物”上市公司全资收购的高科技生物工程制药企业,专门从事基因工程药物和制品的研究开发与生产。目前,公司主要生产海王英特龙-基因重组人干扰素α-2b,即将推出重组人白细胞介素Ⅱ(125ser),同时还在加快几项一、二类生物制品和系列干扰新剂型的开发。经过近两年的发展,英特龙公司由最初的市场跟进者一跃而成为现今市场的主导者,旗下产品干扰素的市场及占有率已位居同行业的前列,成为迄今为止同类产品中销量增长最快产品之一,与此同时,英特龙干扰素已经成为国内知名的干扰素品牌之一。
Shenzhen Neptunus Trilobite Biotechnology Co., Ltd., a subsidiary of Shenzhen Neptunus Group Co., Ltd., was established in January 1999 and is a high-tech bioengineering pharmaceutical company wholly owned by listed companies of “Neptunus Bio”, specializing in genetic engineering drugs and Product research and development and production. At present, the company mainly produces Neptunus-gene recombinant human interferon α-2b, is about to launch recombinant human interleukin Ⅱ (125ser), and is also accelerating the development of several first and second types of biological products and series of new interfering agents . After nearly two years of development, Inteltron has become the leader in the market today with its initial market followers. The market and share of its products, interferon, have been at the forefront of the industry and become the products of its kind to date In one of the fastest growing products in the sales, at the same time, Inter Long Interferon has become one of the well-known brand of interferon.